Granted Patent
B2
US 9,045,494 · App. 14/303,285 · Granted Jun 2, 2015
Orthoester compound
Assignee:
NEKTAR THERAPEUTICS
C07D493/08A61K9/1611A61K9/1617A61K9/1623A61K9/1635A61K9/1652A61K9/209A61K31/74C08G65/002C08G65/331C08G65/332C08G2650/42C08L2203/02C08G65/33317
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A compound is provided that is useful for, among other things, preparing water-soluble polymer derivatives bearing a terminal N-succinimidyl ester.
Claims (1)
1. A compound having the following structure:
Assignments (4)
RELEASE OF SECURITY INTEREST
Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 33760, FRAME 0791
Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036865/0265 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS
Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
SECURITY INTEREST
Recorded Sep 17, 2014
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 033760/0791 →
Continuity (6)
Provisional Application
60409348
· Sep 9, 2002